Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1988-05-18
1989-10-24
Rosen, Sam
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
424101, 514 3, 514 6, 514 7, 514 8, A61K 3702
Patent
active
048762415
ABSTRACT:
A method of inactivating pathogens in proteinaceous biological and pharmaceutical products which comprises: mixing the product in an aqueous solution with one or more primary stabilizers selected from the group consisting of sugars and sugar alcohols and one or more secondary stabilizers selected from the group consisting of sodium acetate, potassium acetate, lithium acetate, magnesium acetate, ammonium acetate, barium acetate, sodium sulfate, ammonium sulfate, lithium sulfate, potassium sulfate and magnesium sulfate; and subjecting said aqueous solution to a pathogen inactivating process.
REFERENCES:
patent: 4297344 (1981-10-01), Schwinn
patent: 4314997 (1982-02-01), Shanbrom
patent: 4379085 (1983-04-01), Williams et al.
patent: 4405603 (1983-09-01), Schwinn et al.
patent: 4440679 (1984-04-01), Fernandes et al.
patent: 4446134 (1984-05-01), Naito et al.
patent: 4456590 (1984-06-01), Rubinstein
patent: 4470968 (1984-09-01), Mitra et al.
patent: 4585654 (1986-04-01), Landaburu et al.
patent: 4673733 (1987-06-01), Chandra et al.
patent: 4721777 (1988-01-01), Wemura et al.
White, G. C., Matthews, T. J., Weinhold, K. J., Haynes, B. F., Cromartie, H. L., McMillan, C. W., and Bolognesi, D. P. (1986), Lancet I, pp. 611-612.
Van Den Berg, W., Ten Cate, J. W., Breederveld, C., and Goudsmit, J. (1986), Lancet I, pp. 803-804.
Colombo, M., Carnelli, V., Gazengel, C., Mannucci, P. M., Savidge, G. F., and Schimpf, K. (1985), Lancet II, pp 1-4.
Preston, F. E., Hay, C. R. M., Dewar, M. S., Greaves, M., Triger, D. R. (1985), Lancet II, p. 213.
McDougal, J. S., Martin, L. S., Cort, S. P., Mozen, M., Heldebrant, C. M., and Evatt, B. L. (1985), J. Clinical Investigation, 76, pp. 875-877.
Hilfenhaus, J., Mauler, R., Friis, R., and Bauer, H. (1985), Proceedings of the Society for Experimental Biology and Medicine, 178, pp. 580-584.
Hilfenhaus, J., Herrmann, A., Mauler, R., and Prince, A. M. (1986), Vox Sang., 50, pp. 208-211.
Hilfenhaus, J., and Weidmann, E. (1986), Drug Research, 36, pp. 621-625.
Piszkiewicz, D., Apfelzweig, R., Bourett, L., Hattley, K., Cabradilla, C. D., McDougal, J. S., and Menache, D. (1988), Transfusion, 28, pp. 198-199.
Mosseler, J., Schimpf, K., Auerswald, G., Bayer, H., Schneider, J., and Hunsmann, G. (1985), Lancet I, p. 1111.
Chandra Sudhish
Feldman Fred
Hrinda Michael E.
Klekamp Mark S.
Shaw Arthur B.
Armour Pharmaceutical Company
Rosen Sam
LandOfFree
Stabilization of biological and pharmaceutical products during t does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Stabilization of biological and pharmaceutical products during t, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Stabilization of biological and pharmaceutical products during t will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1589262